Read + Share
Amedeo Smart
Independent Medical Education
Lan C, Fang G, Qiu C, Li X, et al. Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway. Clin Exp Hypertens 2024;46:2297642.PMID: 38147409
Email
LinkedIn
Facebook
Twitter
Privacy Policy